Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma

BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous melanoma (mCM) patients, but their efficacy in young adults aged less than 40 years remains unclear.Materials and methodsWe retrospectively analyzed 303 stage IV melanoma patients of different ages treate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Machiraju, Devayani (VerfasserIn) , Schäfer, Sarah (VerfasserIn) , Beckhove, Philipp (VerfasserIn) , Roth, Jasmin (VerfasserIn) , Schulz, Carsten (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 January 2023
In: Frontiers in medicine
Year: 2023, Jahrgang: 10, Pages: 1-7
ISSN:2296-858X
DOI:10.3389/fmed.2023.1117816
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2023.1117816
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fmed.2023.1117816
Volltext
Verfasserangaben:Devayani Machiraju, Sarah Schäfer, Philip Beckhove, Jasmin Roth, Carsten Schulz and Jessica C. Hassel
Search Result 1

Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer von Safi, Seyer (VerfasserIn) , Yamauchi, Yoshikane (VerfasserIn) , Hoffmann, Hans (VerfasserIn) , Weichert, Wilko (VerfasserIn) , Jost, Philipp J. (VerfasserIn) , Winter, Hauke (VerfasserIn) , Muley, Thomas (VerfasserIn) , Beckhove, Philipp (VerfasserIn) ,


Volltext
Article (Journal) Online Resource